Less chemoradiation is possible for some cancer patients

Scaling back treatment can mean better quality of life for oropharynx cancer patients who qualify

5:00 AM

Author | Tessa Roy

cancer cell blue yellow
Credit: Justine Ross, Jacob Dwyer, Michigan Medicine

Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center. This could assist many patients in a quicker return to their normal lives. 

Oropharynx cancer was historically related to smoking and alcohol use, but now most cases diagnosed in the United States are caused by the human papillomavirus (HPV). HPV+ oropharynx cancer is recognized as being biologically different from HPV negative cancer, with a better prognosis. 

A standard treatment for oropharynx cancer involves seven weeks of daily radiation – a total of 35 treatments given over the course of five days per week – given with chemotherapy, which causes of side effects like pain, difficulty swallowing, dry mouth, and loss of taste. 

However, most patients with HPV+ oropharynx cancer can be cured with chemoradiation and tend to be younger and healthier compared to those with HPV negative oropharynx cancer. According to the study? That means those patients both may not need the standard amount of treatment and risk being left with the long term toxicities from treatment. 

“Since most patients with HPV+ oropharynx cancer respond very well to treatment and will be cured, there is significant interest in minimizing the amount of treatment they receive to decrease short term side effects and reduce the risk of long term complications,” said Samuel Regan, M.D., a radiation oncology physician at U-M Health. 

“In this study, we hypothesized that patients who have an early response to treatment have more favorable disease that is responsive to radiation, and they could therefore stop early and receive less chemoradiation. Patients who didn't respond quickly still got the standard treatment to ensure we don't compromise the chance of curing their cancer,” adds Michelle Mierzwa, M.D. the primary investigator of the study and associate professor of radiation oncology at U-M Health.   

Experts found that patients who received de-escalated treatment had significantly less weight loss after treatment, tended to need a feeding tube less often, and experienced less worsening of symptoms or less severe symptoms. The study demonstrated that de-escalated chemoradiation is feasible for some patients, and that recurrence rates for patients treated on the trial are similar to those already recorded at Michigan Medicine.   

Though additional research on treatment will be needed, Regan says de-escalated treatments, can make a meaningful difference on a patient’s quality of life. Mierzwa adds that further studies are needed to verify longer term outcomes in these patients.   

"Safely decreasing the amount of chemoradiation needed means that patients could tolerate treatment better and may return back to their normal lives sooner, while keeping the risk of cancer returning low,” Regan said.  

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About: Cancer: Cancer Types Cancer: Help, Diagnosis & Treatment Cancer Diagnosis Cancer Risk Factors Chemotherapy Radiation Oncology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Related
doctor in white coat scanning person in machine with words "lab note" written on yellow badge with blue font bottom right
Health Lab
Statewide quality improvement project reduced excessive radiation treatments for bone metastases by 80%
The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.
Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories surgeon close up operating in bright lighted room
Health Lab
In 10 seconds, AI model detects cancerous brain tumor often missed during surgery
Researchers have developed an AI powered model that — in 10 seconds — can determine during surgery if any part of a cancerous brain tumor that could be removed remains, a study published in Nature suggests.
close up of orange and purple squiggle-looking cells merging and a little green in the middle
Health Lab
Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer
New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.
graphic drawing of woman falling and everything is pink and falling and floating with her like dna strands, cars, people, medicine, ID, blood vessels and cells
Health Lab
Why are more young people being diagnosed with cancer?
An article discusses causes of early-onset cancer and ways to reduce your risk.
Sewing Machine Cell Fabric Tangled
Health Lab
Research points to potential new treatment for aggressive prostate cancer subtype
In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it
purple cells attached and merging
Health Lab
Organoid model predicts bladder cancer treatment response
Researchers have developed a new model to help predict treatment response in patients with bladder cancer. 
little girl smiling on left and on right wearing pink glasses
Health Lab
3-year-old back to cheerful self following complex surgery for rare aggressive chest tumor
A young girl gets back to her childhood after a 3D printed replica of her tumor helps her Michigan Medicine surgical team perform a successful operation.